{"id":"W2099670937","doi":"10.1111/dom.12494","title":"Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial ( <scp>EASE</scp> ‐1)","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Empagliflozin; Placebo; Medicine; Insulin; Type 2 diabetes; Clinical endpoint; Internal medicine; Diabetes mellitus; Randomized controlled trial; Adverse effect; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002829361,0.0004829565,0.002304534,0.000781282,0.0001039419,0.0001381238,0.0002603935,0.0002102287,0.00004437554],"category_scores_gemma":[0.005966654,0.0003276023,0.0002271392,0.0009566046,0.0002253421,0.0002936408,0.0002564288,0.0004516513,0.0002615995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005801835,"about_ca_system_score_gemma":0.0002008591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003649551,"about_ca_topic_score_gemma":0.00001486524,"domain_scores_codex":[0.9959521,0.000630873,0.0006537033,0.0006746635,0.001046197,0.001042487],"domain_scores_gemma":[0.9971098,0.000789021,0.0001794482,0.0005019843,0.0004654384,0.0009543395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7479451,0.004145836,0.2326896,0.0002627516,0.001546108,0.00002398131,0.00136962,0.00003594934,0.00006243814,0.0004744045,0.005326334,0.006117877],"study_design_scores_gemma":[0.9056118,0.00170685,0.08156017,0.0001770173,0.0007946789,7.273913e-8,0.0001049627,0.0003110154,0.0002236366,0.0004830914,0.008814723,0.0002119704],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840603,0.00260284,0.000005321415,0.0002956636,0.0006607667,0.008428663,0.00001322413,0.00008101661,0.003852213],"genre_scores_gemma":[0.9930005,0.00009818818,0.0002981996,0.001401551,0.0004067763,0.0006488858,0.0001049279,0.0000604657,0.003980513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1576667,"threshold_uncertainty_score":0.9999176,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01363860986802511,"score_gpt":0.2461924121162025,"score_spread":0.2325538022481774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}